We are live on ! Find out more
VIMU

Veritas Investment Management (UK) Portfolio holdings

AUM $648M
1-Year Est. Return 36.52%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+36.52%
3 Year Est. Return
+151.05%
5 Year Est. Return
+218.12%
10 Year Est. Return
–
AUM
$260M
AUM Growth
+$1.08M
Cap. Flow
-$14.7M
Cap. Flow %
-5.66%
Top 10 Hldgs %
70.31%
Holding
52
New
3
Increased
4
Reduced
20
Closed
4

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$9.54M
2
LH icon
Labcorp
LH
+$6.05M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$277K
4
CVS icon
CVS Health
CVS
+$236K

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$12.1M
2
WAT icon
Waters Corp
WAT
+$3.88M
3
UNH icon
UnitedHealth
UNH
+$2.14M
4
MSFT icon
Microsoft
MSFT
+$2.14M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 25.2%
2 Technology 19.74%
3 Financials 16.81%
4 Communication Services 15.5%
5 Materials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$23.5M 9.03%
126,657
-12,223
-9% -$2.14M
FNV icon
2
Franco-Nevada
FNV
$41.3B
$23.1M 8.87%
246,671
-3,378
-1% -$239K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.1T
$21.7M 8.34%
128,083
+1,666
+1% +$277K
MSFT icon
4
Microsoft
MSFT
$2.9T
$20.4M 7.83%
295,490
-31,175
-10% -$2.14M
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$19.1M 7.34%
109,425
-5,305
-5% -$891K
CMCSA icon
6
Comcast
CMCSA
$87.3B
$18.8M 7.24%
484,282
-9,603
-2% -$378K
MA icon
7
Mastercard
MA
$498B
$15.4M 5.92%
126,827
-6,670
-5% -$791K
CVS icon
8
CVS Health
CVS
$135B
$14.9M 5.72%
185,104
+2,995
+2% +$236K
CTSH icon
9
Cognizant
CTSH
$25.2B
$12.7M 4.89%
191,410
-3,045
-2% -$193K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.11T
$12.2M 4.69%
268,560
-14,520
-5% -$665K
SLB icon
11
SLB Ltd
SLB
$72.7B
$10.6M 4.06%
160,618
-10,028
-6% -$719K
ACN icon
12
Accenture
ACN
$106B
$9.69M 3.72%
+78,333
New +$9.54M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.12T
$9.27M 3.56%
199,360
-29,400
-13% -$1.38M
LH icon
14
Labcorp
LH
$25.2B
$7.12M 2.74%
53,788
+49,435
+1,136% +$6.05M
TSM icon
15
TSMC
TSM
$1.94T
$6.74M 2.59%
192,680
-348,582
-64% -$12.1M
MCO icon
16
Moody's
MCO
$83.7B
$5.17M 1.99%
42,490
-4,625
-10% -$541K
PM icon
17
Philip Morris
PM
$309B
$2.17M 0.83%
18,455
-7,015
-28% -$812K
HON icon
18
Honeywell
HON
$76.4B
$1.79M 0.69%
14,834
-996
-6% -$118K
MO icon
19
Altria Group
MO
$125B
$1.33M 0.51%
17,860
– –
FISV
20
Fiserv Inc
FISV
$29.7B
$1.29M 0.5%
21,160
-3,010
-12% -$182K
NTRS icon
21
Northern Trust
NTRS
$21.8B
$1.07M 0.41%
11,000
– –
PG icon
22
Procter & Gamble
PG
$340B
$612K 0.24%
7,025
– –
MRK icon
23
Merck
MRK
$322B
$453K 0.17%
7,409
– –
GE icon
24
GE Aerospace
GE
$364B
$396K 0.15%
3,057
– –
KO icon
25
Coca-Cola
KO
$383B
$396K 0.15%
8,830
– –
1
2

Similar funds

HAM
Hillcrest Asset Management Plano, Texas $656M AUM 31.12% 1-Year Est. Return
AC
Alley Company Lake Forest, Illinois $631M AUM 24.9% 1-Year Est. Return
SIM
SCGF III Management Menlo Park, California $673M AUM
CCC
Crescent Capital Consulting New Orleans, Louisiana $607M AUM 22.88% 1-Year Est. Return
BCA
Biltmore Capital Advisors Princeton, New Jersey $599M AUM 20.23% 1-Year Est. Return
QCM
Quest Capital Management Dallas, Texas $582M AUM 31.4% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
NG
Newmark Group New York $525M AUM

Veritas Investment Management (UK)'s Q2 2017 Portfolio in Review

As of Q2 2017, Veritas Investment Management (UK) held 52 positions worth $260M, up 0.42% from $259M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Veritas Investment Management (UK) withdrew a net $14.7M in Q2 2017, closing 4 positions and reducing 20 holdings. Its most notable exit was Waters Corp, an estimated $3.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

Against the trend, Veritas Investment Management (UK) opened a new position in Accenture worth $9.69M.

  • Veritas Investment Management (UK)'s largest Q2 2017 buy was Accenture: 78,333 shares worth $9.69M.
  • Veritas Investment Management (UK) added most to Labcorp in Q2 2017, an estimated $6.05M increase.
  • Veritas Investment Management (UK)'s biggest Q2 2017 reduction was TSMC, cutting an estimated $12.1M.
  • Veritas Investment Management (UK) fully exited Waters Corp in Q2 2017, selling an estimated $3.88M.
  • Veritas Investment Management (UK)'s ten largest holdings make up 70% of its $260M portfolio in Q2 2017.
  • Veritas Investment Management (UK) opened 3 new positions and closed 4 in Q2 2017.
  • Veritas Investment Management (UK)'s portfolio value rose 0.42% quarter-over-quarter to $260M.

Based on Veritas Investment Management (UK)'s 13F filing for Q2 2017, filed 9 Aug 2017.